C84.66
Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. When this lymphoma is ALK-positive, it indicates the presence of a specific abnormal protein that can influence the disease's behavior and treatment options. The IC-10 code C84.66 specifically refers to ALK-positive ALCL located in the intrapelvic lymph nodes. This form of lymphoma usually affects adults and can sometimes involve other parts of the body, but intrapelvic lymph nodes are a common site of diagnosis.
Causes & Symptoms
Clinical Causes: Unknown exact cause; it involves abnormal growth of lymphocytes, a type of white blood cell. Genetic mutations, including the presence of the ALK gene rearrangement. Possible environmental exposures, though no definitive links have been established. Immune system deficiencies may increase risk.
Key Symptoms: Swelling or painless lumps in the groin, pelvis, or abdomen. Persistent fatigue and weakness. Unexplained weight loss. Fever that does not go away. Night sweats. Discomfort or pain in the affected area. Possible symptoms related to pressure on nearby organs.
Diagnostic & Treatment
Diagnosis Path: Diagnosing ALK-positive anaplastic large cell lymphoma involves several steps:
Treatment Protocols: Treatment strategies for ALK-positive ALCL typically include:
Clinical Advice & FAQs
Billing Guidance
Is C84.66 a billable ICD-10 code?
Yes, C84.66 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.66?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference